Hypomethylating agents for low risk MDS
Eunice Wang, MD, of Roswell Park Comprehensive Cancer Center, Buffalo, NY, discusses extending the use of hypomethylating agents from patients with high risk myelodysplastic syndromes (MDS) to individ...
Author: VJHemOnc
Added: 08/15/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts